Want to see AFIB full AI Analyst Report?
AFIB Stock Chart & Stats
$0.01
$0.02(30.00%)
At close: 4:00 PM EST
$0.01
$0.02(30.00%)
Day’s Range― - ―
52-Week Range$0.00 - $0.22
Previous CloseN/A
Volume48.35K
Average Volume (3M)20.94K
Market Cap
$2.99K
Enterprise Value$21.75M
Total Cash (Recent Filing)$14.02M
Total Debt (Recent Filing)$35.76M
Price to Earnings (P/E)―
Beta-50.78
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding29,912,306
10 Day Avg. Volume19,516
30 Day Avg. Volume20,944
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.14
Price to Sales (P/S)0.08
P/FCF Ratio-0.05
Enterprise Value/Market Cap7.27K
Enterprise Value/Revenue1.08
Enterprise Value/Gross Profit21.66
Enterprise Value/Ebitda9.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Innovative Product OfferingAcutus Medical's focus on innovative cardiac mapping systems positions it well in the growing electrophysiology market, offering potential for long-term growth through advanced medical technology.
Revenue ModelThe recurring revenue model from disposable catheters and service agreements provides a stable income stream, supporting long-term financial sustainability and customer retention.
Market FocusSpecialization in electrophysiology allows Acutus Medical to capitalize on growing demand for cardiac arrhythmia solutions, enhancing its competitive position in a niche market.
Bears Say
Financial InstabilityPersistent financial instability with negative cash flows and high leverage poses significant risks to long-term viability, limiting the company's ability to invest in growth or weather downturns.
Negative Cash FlowOngoing negative cash flows hinder Acutus Medical's ability to generate free cash, affecting its capacity to fund operations and invest in future growth, which could impact long-term sustainability.
Balance Sheet ConcernsA highly leveraged balance sheet with negative equity suggests financial distress, reducing financial flexibility and increasing insolvency risk, which could affect the company's long-term operational capabilities.
Acutus Medical News
AFIB FAQ
What was Acutus Medical’s price range in the past 12 months?
Acutus Medical lowest stock price was $0.00 and its highest was $0.22 in the past 12 months.
What is Acutus Medical’s market cap?
Acutus Medical’s market cap is $2.99K.
When is Acutus Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acutus Medical’s earnings last quarter?
Currently, no data Available
Is Acutus Medical overvalued?
According to Wall Street analysts Acutus Medical’s price is currently Overvalued.
Does Acutus Medical pay dividends?
Acutus Medical does not currently pay dividends.
What is Acutus Medical’s EPS estimate?
Acutus Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acutus Medical have?
Acutus Medical has 29,912,306 shares outstanding.
What happened to Acutus Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acutus Medical?
Currently, no hedge funds are holding shares in AFIB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Acutus Medical
Acutus Medical, Inc. is a company dedicated to the treatment of cardiac arrhythmias, focusing on the design, manufacturing, and commercialization of specialized tools for catheter-based ablation procedures. These solutions are utilized to manage a spectrum of heart rhythm disorders across both domestic U.S. and international markets. The firm's extensive product offerings include innovative access sheaths, transseptal crossing devices, diagnostic and mapping catheters, along with both traditional and contact-force ablation catheters. It also provides advanced mapping and imaging consoles, accompanying accessories, and vital supporting algorithms and software. Acutus Medical, Inc. was established in 2011 and is headquartered in Carlsbad, California.
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---